3Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007[J].CA Cancer J Clin,2007,57(1):43-66.
4Matsumoto H,Wada T,Fukunaga K,et al.Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer[J].Jpn J Clin Oncol,2004,34(3):124-130.
5Lopez Saez J B,Gomez Biondi V,Santamaria Rodriguez G.Concurrent overexpression of serum p53 mutation related with Helicobacter pylori infection[J].J Exp Clin Cancer Res,2010,29:65.
6Veliikovic L J,Dordevic B,Rancic G,et al.Expression of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma[J].Vojnosanit Pregl,2007,64(5):325-330.
7Pearl R A,Pacifico M D,Richman P I,et al.Ki-67 expression in melanoma.A potential method of risk assessment for the patient with a positive sentinel node[J].Exp Clin Cancer Res,2007,26(1):109-115.
8Ionescu D N,Sasatomi E,Cieply K,et al.Protein expression and gene amplification of epidermal growth factor receptor in thymomas[J].Cancer,2005,103(3):630-636.
9Goldhirsch A,Wood WC,Coates AS. Strategies for subtypes-dealing with the diversity of breast cancer:highlights of the St gallen international expert consensus on the primary therapy of early breast cancer 2011[J].Annals of Oncology,2011,(08):1736-1747.
10Tanaka K,Iwamoto S,Gon G. Express ion of survivin and its relationship to loss of apoptosis in breast carcinomas[J].Clinical Cancer Research,2000,(01):127-134.
